Exome Asset Management LLC

SEC CIK: 0002011932
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by Exome Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overview All 13F holders of VRDN Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2024

Holdings of VRDN by Exome Asset Management LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−217,294−100.0%	Sold out	Holders
Q1 2025	217,294	$2.93M	2.6%	+217,294	New	Holders
Q4 2024	0	$0	0.0%	−174,400−100.0%	Sold out	Holders
Q3 2024	174,400	$3.97M	2.7%	+174,400	New	Holders